Ken Griffin Lixte Biotechnology Hldgs Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lixte Biotechnology Hldgs Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 32,122 shares of LIXTW stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,122Holding current value
$0% of portfolio
0.0%Shares
2 transactions